Pablo Rabes-Aguero
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Eligibility for lecanemab therapy in a biomarker defined memory clinic cohort: A five-year analysis.
Eligibility for lecanemab therapy in a biomarker defined memory clinic cohort: A five-year analysis.
Journal: Journal of Alzheimer's disease : JAD
Published: July 08, 2026
MAPT p.V363I mutation in a patient with presenile dementia and late amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: December 27, 2025
Clinical phenotype of frontotemporal dementia associated with the Pro392Leu SQSTM1 mutation.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 23, 2025
Plasma Biomarkers in the Distinction of Alzheimer's Disease and Frontotemporal Dementia.
Journal: International journal of molecular sciences
Published: December 20, 2024
Plasma Neurodegenerative Biomarkers in Cognitively Preserved Nonagenarians.
Journal: Aging and disease
Published: October 01, 2024
ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels.
Journal: International journal of molecular sciences
Published: February 14, 2023
TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 08, 2022
Presence of tau astrogliopathy in frontotemporal dementia caused by a novel Grn nonsense (Trp2*) mutation.
Journal: Neurobiology of aging
Published: May 30, 2018
Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists.
Journal: Stroke research and treatment
Published: March 12, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026